Recently, secreted adipokine neuregulin 4 (Nrg4) has been identified as playing an important role in modulating systemic energy metabolism and in the development of obesity-associated disorders, including type 2 diabetes and nonalcoholic fatty liver disease (NAFLD)14. Here, NRG4 is linked to metabolic dysfunction-associated steatotic liver disease.